| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |